Aerie Pharmaceuticals' IPO

Aerie Pharmaceuticals raised a round of funding on October 25, 2013. Investors include Public.

Aerie Pharmaceuticals is a privately held, clinical-stage biotechnology company dedicated to the discovery and development of novel treatments for glaucoma. All technology of the company is based on i…

Articles about Aerie Pharmaceuticals' IPO: